$VEEA
VEEA INC.

2022 Q4 Form 10-K Financial Statement

#000119312523103855 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.388M $4.074M
YoY Change -8.85% 39.68%
Operating Profit -$4.074M
YoY Change
Interest Expense $3.230M $13.65M
YoY Change 61.86% 48.5%
% of Operating Profit
Other Income/Expense, Net $1.000M $14.65M
YoY Change -49.75% 59.61%
Pretax Income $2.842M $10.58M
YoY Change 113.89% 60.42%
Income Tax
% Of Pretax Income
Net Earnings $2.842M $10.58M
YoY Change 113.89% 60.42%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.07 $0.27
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $86.40K $86.40K
YoY Change -19.42% -19.42%
Cash & Equivalents $86.40K
Short-Term Investments
Other Short-Term Assets $43.63K $43.63K
YoY Change -87.3% -87.3%
Inventory
Prepaid Expenses $43.63K
Receivables
Other Receivables
Total Short-Term Assets $130.0K $130.0K
YoY Change -71.16% -71.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $4.577M
YoY Change
Intangibles
YoY Change
Long-Term Investments $323.9M $323.9M
YoY Change 1.47% 1.47%
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $323.9M $323.9M
YoY Change 1.45% 1.45%
TOTAL ASSETS
Total Short-Term Assets $130.0K $130.0K
Total Long-Term Assets $323.9M $323.9M
Total Assets $324.0M $324.0M
YoY Change 1.35% 1.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.641M $2.641M
YoY Change 150.09% 150.09%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.000M $1.000M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.876M $3.876M
YoY Change 231.0% 231.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $11.55M $11.55M
YoY Change -43.72% -43.72%
Total Long-Term Liabilities $11.55M $11.55M
YoY Change -43.72% -43.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.876M $3.876M
Total Long-Term Liabilities $11.55M $11.55M
Total Liabilities $15.43M $15.43M
YoY Change -28.89% -28.89%
SHAREHOLDERS EQUITY
Retained Earnings -$15.30M
YoY Change -27.77%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.30M $308.6M
YoY Change
Total Liabilities & Shareholders Equity $324.0M $324.0M
YoY Change 1.35% 1.35%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $2.842M $10.58M
YoY Change 113.89% 60.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$272.5K -$1.021M
YoY Change 4.39% -52.26%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 250.0K 1.000M
YoY Change -99.69%
NET CHANGE
Cash From Operating Activities -272.5K -1.021M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 250.0K 1.000M
Net Change In Cash -22.45K -20.82K
YoY Change -91.4% -119.42%
FREE CASH FLOW
Cash From Operating Activities -$272.5K -$1.021M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001840317
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
PLUM ACQUISITION CORP. I
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity File Number
EntityFileNumber
001-40218
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1577353
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
2021 Fillmore St. #2089
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94115
CY2022 dei City Area Code
CityAreaCode
415
CY2022 dei Local Phone Number
LocalPhoneNumber
683-6773
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
309959066
CY2022 plmi Number Of Days After The Closing Of The Initial Business Combination To File With The Sec
NumberOfDaysAfterTheClosingOfTheInitialBusinessCombinationToFileWithTheSec
P20D
CY2023Q2 plmi Redeemable Period Of Public Share
RedeemablePeriodOfPublicShare
P10D
CY2021Q1 plmi Consummation Of The Initial Business Combination
ConsummationOfTheInitialBusinessCombination
P2D
CY2022 dei Auditor Firm
AuditorFirmId
688
CY2022 dei Auditor Name
AuditorName
Marcum LLP
CY2022 dei Auditor Location
AuditorLocation
New York, NY
CY2022Q4 us-gaap Cash
Cash
86401
CY2021Q4 us-gaap Cash
Cash
107224
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
43631
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
343630
CY2022Q4 us-gaap Assets Current
AssetsCurrent
130032
CY2021Q4 us-gaap Assets Current
AssetsCurrent
450854
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
0
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
48795
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
323911642
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
319232602
CY2022Q4 us-gaap Assets
Assets
324041674
CY2021Q4 us-gaap Assets
Assets
319732251
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2640756
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1055936
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
235000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
115000
CY2022Q4 plmi Convertible Promissory Note Related Party
ConvertiblePromissoryNoteRelatedParty
1000000
CY2021Q4 plmi Convertible Promissory Note Related Party
ConvertiblePromissoryNoteRelatedParty
0
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3875756
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1170936
CY2022Q4 plmi Warrant Liability
WarrantLiability
379217
CY2021Q4 plmi Warrant Liability
WarrantLiability
9352739
CY2022Q4 plmi Deferred Underwriting Commissions Liability
DeferredUnderwritingCommissionsLiability
11172572
CY2021Q4 plmi Deferred Underwriting Commissions Liability
DeferredUnderwritingCommissionsLiability
11172572
CY2022Q4 us-gaap Liabilities
Liabilities
15427545
CY2021Q4 us-gaap Liabilities
Liabilities
21696247
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15298312
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21181135
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-15297513
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21180336
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
324041674
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
319732251
CY2022 plmi Formation And Operating Costs
FormationAndOperatingCosts
4074437
plmi Formation And Operating Costs
FormationAndOperatingCosts
2916919
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-4074437
us-gaap Operating Income Loss
OperatingIncomeLoss
-2916919
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8973522
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9177618
CY2022 plmi Stock Issuance Costs
StockIssuanceCosts
0
plmi Stock Issuance Costs
StockIssuanceCosts
564701
CY2022 plmi Gain On Expiration Of Over Allotment Option
GainOnExpirationOfOverAllotmentOption
0
plmi Gain On Expiration Of Over Allotment Option
GainOnExpirationOfOverAllotmentOption
881755
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
0
us-gaap Interest Income Operating
InterestIncomeOperating
2
CY2022 plmi Termination Fee
TerminationFee
1000000
plmi Termination Fee
TerminationFee
0
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
4679040
us-gaap Investment Income Interest
InvestmentIncomeInterest
16262
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14652562
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9510936
CY2022 us-gaap Net Income Loss
NetIncomeLoss
10578125
us-gaap Net Income Loss
NetIncomeLoss
6594017
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0
plmi Stock Issued During Period Value New Issues To Sponsor
StockIssuedDuringPeriodValueNewIssuesToSponsor
25000
plmi Initial Classification Of Overallotment Liability
InitialClassificationOfOverallotmentLiability
-1170000
plmi Partial Exercise Of Overallotment Options
PartialExerciseOfOverallotmentOptions
288245
plmi Adjustments To Additional Paid In Capital Excess Cash Received Over Fair Value Of Private Placement Warrants
AdjustmentsToAdditionalPaidInCapitalExcessCashReceivedOverFairValueOfPrivatePlacementWarrants
208184
us-gaap Net Income Loss
NetIncomeLoss
6594017
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
27125782
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-21180336
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4695302
CY2022 us-gaap Net Income Loss
NetIncomeLoss
10578125
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-15297513
CY2022 us-gaap Net Income Loss
NetIncomeLoss
10578125
us-gaap Net Income Loss
NetIncomeLoss
6594017
CY2022 plmi Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
4679040
plmi Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
16262
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-8973522
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9177618
CY2022 plmi Stock Issuance Costs
StockIssuanceCosts
0
plmi Stock Issuance Costs
StockIssuanceCosts
564701
CY2022 plmi Gain On Expiration Of Over Allotment Option
GainOnExpirationOfOverAllotmentOption
0
plmi Gain On Expiration Of Over Allotment Option
GainOnExpirationOfOverAllotmentOption
881755
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-348794
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
392425
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
120000
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
115000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1584820
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1055936
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1020823
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2138406
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
319216340
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-319216340
CY2022 plmi Proceeds From Sale Of Ordinary Shares To Initial Shareholders
ProceedsFromSaleOfOrdinarySharesToInitialShareholders
0
plmi Proceeds From Sale Of Ordinary Shares To Initial Shareholders
ProceedsFromSaleOfOrdinarySharesToInitialShareholders
25000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
312832013
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
9384327
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
779370
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
321461970
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20823
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107224
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107224
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86401
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
107224
CY2022 plmi Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
4695302
plmi Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
27125782
CY2022 plmi Deferred Underwriting Commissions Charged To Additional Paid In Capital
DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital
0
plmi Deferred Underwriting Commissions Charged To Additional Paid In Capital
DeferredUnderwritingCommissionsChargedToAdditionalPaidInCapital
11172572
CY2022 plmi Founder Shares Forfeited Value
FounderSharesForfeitedValue
0
plmi Founder Shares Forfeited Value
FounderSharesForfeitedValue
64
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
30000000
CY2021Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
19216340
CY2021Q1 plmi Stock Issuance Costs
StockIssuanceCosts
538777
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
17797492
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
319216340
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10
CY2021Q1 us-gaap Share Price
SharePrice
10
CY2023Q2 plmi Interest To Pay Dissolution Expenses
InterestToPayDissolutionExpenses
100000
CY2021Q1 plmi Public Share Redeemable Percentage
PublicShareRedeemablePercentage
1
CY2022 plmi Working Capital Loans
WorkingCapitalLoans
1000000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates. </div>
CY2022 plmi Convertible Promissory Note
ConvertiblePromissoryNote
<div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Convertible Promissory Note </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its convertible promissory note under ASC 815, “Derivatives and Hedging” (“ASC 815”). Under <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">815-15-25,</div></div> the election can be at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825, “Financial Instruments” (“ASC 825”). The Company has made such election for its convertible promissory note. Using fair value option, the convertible promissory note is required to be recorded at its initial fair value on the date of issuance and each balance sheet date thereafter. Differences between the face value of the note and fair value at issuance are recognized as either an expense in the statements of operations (if issued at a premium) or as a capital contribution (if issued at a discount). Changes in the estimated fair value of the notes are recognized as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> gains or losses in the statements of operations. </div>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 12pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022 plmi Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
9354214
plmi Proceeds Allocated To Public Warrants
ProceedsAllocatedToPublicWarrants
9354214
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
31921634
plmi Number Of Trading Days
NumberOfTradingDays
P30D
CY2021Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
644591
CY2021Q2 plmi Founder Shares Forfeited Shares
FounderSharesForfeitedShares
644591
CY2022Q4 plmi Working Capital Loan
WorkingCapitalLoan
1000000
CY2022 plmi Number Of Days After The Closing Of The Initial Business Combination For Registration Statement To Be Effective
NumberOfDaysAfterTheClosingOfTheInitialBusinessCombinationForRegistrationStatementToBeEffective
P60D
CY2022 plmi Percentage Proceeds From Issuances To Total Equity Proceeds
PercentageProceedsFromIssuancesToTotalEquityProceeds
0.60
CY2022Q4 plmi Overallotment Liability
OverallotmentLiability
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
-4181839
CY2022Q4 plmi Deferred Underwriting Commissions Payable
DeferredUnderwritingCommissionsPayable
11172572
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 plmi Founder Shares Forfeited Shares
FounderSharesForfeitedShares
644591
CY2022 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of the Class A ordinary shares and holders of the Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders, except as required by law.
CY2022 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
one-to-one

Files In Submission

Name View Source Status
0001193125-23-103855-index-headers.html Edgar Link pending
0001193125-23-103855-index.html Edgar Link pending
0001193125-23-103855.txt Edgar Link pending
0001193125-23-103855-xbrl.zip Edgar Link pending
d485721d10k.htm Edgar Link pending
d485721dex1013.htm Edgar Link pending
d485721dex311.htm Edgar Link pending
d485721dex312.htm Edgar Link pending
d485721dex321.htm Edgar Link pending
d485721dex322.htm Edgar Link pending
d485721dex42.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g485721g13v10.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
plmi-20221231.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
plmi-20221231_lab.xml Edgar Link unprocessable
plmi-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d485721d10k_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
plmi-20221231_cal.xml Edgar Link unprocessable
plmi-20221231_def.xml Edgar Link unprocessable